These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563 [TBL] [Abstract][Full Text] [Related]
4. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Rajasekaran M; Brents LK; Franks LN; Moran JH; Prather PL Toxicol Appl Pharmacol; 2013 Jun; 269(2):100-8. PubMed ID: 23537664 [TBL] [Abstract][Full Text] [Related]
5. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154 [TBL] [Abstract][Full Text] [Related]
7. Similarities and differences upon binding of naturally occurring Δ Raïch I; Rivas-Santisteban R; Lillo A; Lillo J; Reyes-Resina I; Nadal X; Ferreiro-Vera C; de Medina VS; Majellaro M; Sotelo E; Navarro G; Franco R Pharmacol Res; 2021 Dec; 174():105970. PubMed ID: 34758399 [TBL] [Abstract][Full Text] [Related]
8. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal. Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptors: nomenclature and pharmacological principles. Console-Bram L; Marcu J; Abood ME Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):4-15. PubMed ID: 22421596 [TBL] [Abstract][Full Text] [Related]
10. Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors. Song S; Kong X; Borlongan C; Sava V; Sanchez-Ramos J Cannabis Cannabinoid Res; 2021; 6(1):48-57. PubMed ID: 33614952 [No Abstract] [Full Text] [Related]
11. Cannabinoid CB1 and CB2 receptors differentially modulate L- and T-type Ca Qian WJ; Yin N; Gao F; Miao Y; Li Q; Li F; Sun XH; Yang XL; Wang Z Neuropharmacology; 2017 Sep; 124():143-156. PubMed ID: 28431968 [TBL] [Abstract][Full Text] [Related]
12. Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons. Stumpf A; Parthier D; Sammons RP; Stempel AV; Breustedt J; Rost BR; Schmitz D Neuropharmacology; 2018 Sep; 139():217-225. PubMed ID: 30025920 [TBL] [Abstract][Full Text] [Related]
13. CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen. Prather PL; FrancisDevaraj F; Dates CR; Greer AK; Bratton SM; Ford BM; Franks LN; Radominska-Pandya A Biochem Biophys Res Commun; 2013 Nov; 441(2):339-43. PubMed ID: 24148245 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of cannabinoid receptor ligands: current status. Singh J; Budhiraja S Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344 [TBL] [Abstract][Full Text] [Related]
15. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects. Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336 [TBL] [Abstract][Full Text] [Related]
16. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells. Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. McHugh D; Tanner C; Mechoulam R; Pertwee RG; Ross RA Mol Pharmacol; 2008 Feb; 73(2):441-50. PubMed ID: 17965195 [TBL] [Abstract][Full Text] [Related]
19. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Pertwee RG Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291 [TBL] [Abstract][Full Text] [Related]
20. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons. Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]